Recruiting Urticaria Studies in Santa Monica
A Study of Navenibart in Participants With Hereditary Angioedema
This is a Phase 3 multicenter, randomized, double-blind, placebo-controlled clinical trial evaluating the safety and efficacy of subcutaneous administration of navenibart in adult and adolescent parti...
Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE
This is a Phase 3, multicenter, long-term, open-label study to evaluate the safety and efficacy of once-daily orally administered deucrictibant extended-release tablet for prophylaxis to prevent angio...
Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema
This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled, 2-period, 2-treatment cross-over study to evaluate the efficacy and safety of orally administered deucrictibant compared t...
Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE
This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of once-daily orally administered deucrictibant extended-release tablet compared ...
Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With HAE Type I or II
KVD900-303 is an open-label, multicenter clinical trial in patients aged 2 to 11 years old with HAE Type I or II....
Safety Study in Subjects ≥ 12 Years of Age With Hereditary Angioedema Switching to Garadacimab
This study is designed to evaluate the safety after switching to garadacimab from another prophylactic hereditary angioedema (HAE) treatment (marketed kallikrein \[KK\] inhibitor or plasma-derived C1-...
About Urticaria Clinical Trials in Santa Monica
Urticaria (hives) presents as raised, itchy welts on the skin triggered by allergens, medications, infections, or other factors. Acute urticaria resolves within six weeks, while chronic forms persist longer. Treatment includes antihistamines, corticosteroids for severe episodes, and biologics for chronic cases.
There are currently 6 urticaria clinical trials recruiting participants in Santa Monica, CALIFORNIA. These studies are seeking a combined 554 participants. Research is being sponsored by Astria Therapeutics, Inc., Pharvaris Netherlands B.V., KalVista Pharmaceuticals, Ltd. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Urticaria Clinical Trials in Santa Monica — FAQ
Are there urticaria clinical trials in Santa Monica?
Yes, there are 6 urticaria clinical trials currently recruiting in Santa Monica, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Santa Monica?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Santa Monica research site will contact you about next steps.
Are clinical trials in Santa Monica free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Santa Monica studies also compensate for your time and travel.
What urticaria treatments are being tested?
The 6 active trials in Santa Monica are testing new therapies including novel drugs, biologics, and treatment approaches for urticaria.
Data updated March 2, 2026 from ClinicalTrials.gov